Atossa Therapeutics Inc logo

Atossa Therapeutics Inc

$ 0.75 -0.0122 (-1.6%) 10:08 PM EST
P/E:
At Loss
P/B:
0.77
Market Cap:
$ 94.97M
Enterprise V:
$ -43.53M
Volume:
348.61K
Avg Vol (2M):
437.56K
Also Trade In:
Volume:
348.61K
Market Cap $:
94.97M
PE Ratio:
At Loss
Avg Vol (2-Month):
437.56K
Enterprise Value $:
-43.53M
PB Ratio:
0.77
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.98
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.09
9-Day RSI 35.38
14-Day RSI 38.39
6-1 Month Momentum % 1.33
12-1 Month Momentum % -56.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 43.02
Quick Ratio 43.02
Cash Ratio 40.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -178.7
Name Current Vs Industry Vs History
ROE % -18.17
ROA % -17.8
ROIC % -674.98
ROC (Joel Greenblatt) % -1330.8
ROCE % -18.22

Financials (Next Earnings Date:2023-02-28 Est.)

ATOS's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:ATOS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.19
Beta 0.76
Volatility % 48.74
14-Day RSI 38.39
14-Day ATR ($) 0.045352
20-Day SMA ($) 0.810705
12-1 Month Momentum % -56.6
52-Week Range ($) 0.75 - 2.305
Shares Outstanding (Mil) 126.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Atossa Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Atossa Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.